ConductScience.org, home

Gene271

AMPD2: adenosine monophosphate deaminase 2

Cite this record

ConductScience Library. AMPD2: adenosine monophosphate deaminase 2. Genes, record 271. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/271

FollowSave as evidenceDownload JSON
Sources
13 sources
Release
gene-search-2026-11-13-0.2.1

Gene

Symbol
AMPD2
HGNC
Name
adenosine monophosphate deaminase 2
HGNC
NCBI Gene ID
271
NCBI Gene
HGNC ID
HGNC:469
HGNC
Ensembl
ENSG00000116337
NCBI Gene
Aliases
AMPD, PCH9, SPG63
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q01433AMP deaminase 28255Ensembl, GeneID, HGNC

Source UniProt

Download CSV of proteins

Patents5

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-191589Q01433Espacenet
US 20250320254 A12025-10-161589Q01433Espacenet
JP 2025517970 A2025-06-121589Q01433Espacenet
US 20240398993 A12024-12-0552272Q01433Espacenet
US 20220205030 A12022-06-306Q01433Espacenet

Download CSV of patents

NIH grants280

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleAMPD2 papersNewest fiscal year
P30DK048520Colorado Nutrition Obesity Research Center32025
R35NS105078STRUCTURAL VARIATION IN NEUROLOGICAL DISEASE22025
P01AG019724Frontotemporal Dementia: Genes, Images, and Emotions12025
P20GM103476Mississippi INBRE12025
P30AG072975Rush Alzheimer's Disease Research Center12025
P30AI027763UCSF-Bay Area Center for AIDS Research12025
P30CA022453CANCER CENTER SUPPORT GRANT12025
P30CA044579University of Virginia Cancer Center Support Grant12025
P30CA046934University of Colorado Cancer Center Support Grant12025
P30CA068485Cancer Center Support Grant12025

Source NIH's project files

See all 280 nih grantsDownload CSV of nih grants

Papers327

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Folic acid alleviates neuroinflammation after intracerebral hemorrhage by epigenetically regulating the AMPD2/DCK/NF-κB pathway.Phytomedicine202642542053PubTator, text miningPubMed
Clinical and genetic characteristics of pediatric hereditary spastic paraplegia in the Eastern Levant.Eur J Paediatr Neurol202642462372PubTator, text miningPubMed
Deciphering AMP deaminase-2 structure, activators and regulators underpinning cellular function in human fructose and nucleotide metabolism.bioRxiv202642327085PubTator, text miningPubMed
Identification of AMPD2 allosteric inhibitors with novel mechanism of action by fragment merging approach.SLAS Discov202642177948PubTator, text miningPubMed
Functional Characterization of a Novel Splice-Altering Intronic Variant in AMPD2 Associated with Pontocerebellar Hypoplasia Type 9.Cerebellum202642115434PubTator, text miningPubMed
Pontocerebellar hypoplasia type 9 with a novel combination of compound heterozygous variants in AMPD2.Hum Genome Var202642026036PubTator, text miningPubMed
Multi-platform integration of brain and CSF proteomes reveals biomarker panels for Alzheimer's disease.Brief Bioinform202641608987PubTator, text miningPubMed
MIF Facilitates Resistance to Androgen Deprivation Therapy by Regulating AMPD2 Expression in Prostate Cancer Cells.Prostate202640968720PubTator, text miningPubMed
APOBEC3B Promotes SARS-CoV-2 Through Activation of PKR/eIF2⍺ and AMPD2 Dysregulation.Viruses202541012606PubTator, text miningPubMed
Pontocerebellar hypoplasia: a review from 1912 to 2022.Brain Commun202540936650PubTator, text miningPubMed

See all 327 papersDownload CSV of papers

None in this release

  • Drugs
  • Trials

Sources 13

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
  • USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
  • USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/271

GET https://conductscience.org/api/genes/v1/271/grants?page=2